Outcome of allogeneic haematopoetic stem cell transplantation for patients with primary or secondary resistance to imatinib in chronic myeloid leukaemia

被引：0
作者：
Koldehoff, M [1 ]
Elmaagacli, AH [1 ]
Steckel, NK [1 ]
Hlinka, M [1 ]
Ditschkowski, M [1 ]
Trenschel, R [1 ]
Peceny, R [1 ]
Beelen, DW [1 ]
机构：
[1] Univ Hosp, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [31] Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia
    Olavarria, E
    Ottmann, OG
    Deininger, M
    Clark, RE
    Bandini, G
    Byrne, J
    Lipton, J
    Vitek, A
    Michallet, M
    Siegert, W
    Ullmann, A
    Wassmann, B
    Niederwieser, D
    Fischer, T
    [J]. LEUKEMIA, 2003, 17 (09) : 1707 - 1712
  • [32] One year follow-up of chronic myeloid leukaemia patients, who received imatinib prior to myeloablative allogeneic stem cell transplantation
    Zaucha, JM
    Prejzner, W
    Giebel, S
    Szatkowski, D
    Balon, J
    Wojnar, J
    Kruzel, T
    Kalwak, K
    Holowiecki, J
    Hellmann, A
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S237 - S238
  • [33] Reduced-intensity allogeneic stem cell transplantation to complement therapy with imatinib for eradication of minimal residual disease in chronic myeloid leukaemia patients
    Copland, M
    Heaney, N
    Stewart, K
    Godden, J
    Smith, G
    Crawley, C
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S206 - S206
  • [34] The impact of second generation tyrosine kinase inhibitors on the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia
    Latif, A.
    Parker, A.
    McQuaker, G.
    Clark, A.
    Copland, M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 23 - 24
  • [35] Imatinib for chronic myeloid leukaemia relapsing after allogeneic bone marrow transplantation
    Lucesole, M
    Garuti, A
    Sessarego, M
    Di Grazia, C
    van Lint, MT
    Dominietto, A
    Raiola, AM
    Lamparelli, T
    Gualandi, F
    Occhini, D
    Bregante, S
    Galbusera, V
    Bacigalupo, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S150 - S150
  • [36] Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era
    Grigg, Andrew
    Hughes, Timothy
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (08) : 795 - 807
  • [37] Allogeneic stem cell transplantation in patients with chronic myeloid leukaemia: application of the EBMT risk scoring system
    Novella, E
    Madeo, D
    Raimondi, R
    Cappellari, A
    Guercini, N
    Montaldi, AM
    Roberti, S
    Rodeghiero, F
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S235 - S235
  • [38] Allogeneic stem cell transplantation for chronic myeloid leukaemia after imatinib-based primary therapy: the major determinant of transplant outcome remains the pre-transplant risk score
    Beelen, D.
    Koldehoff, M.
    Elmaagacli, A.
    Ottinger, H.
    Peceny, R.
    Trenschel, R.
    Steckel, N.
    Ditschkowski, M.
    Hlinka, M.
    Engelhard, M.
    Kordelas, L.
    Schulte, C.
    Grosse-Wilde, H.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S8 - S8
  • [39] Allogeneic haematopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia
    Zaucha, J. M.
    Bieniaszewska, M.
    Piekarska, A.
    Prejzner, W.
    Knopinska-Posluszny, W.
    Hellmann, A.
    [J]. BONE MARROW TRANSPLANTATION, 2007, 39 : S316 - S316
  • [40] Staging criteria based on maximal disease stage pre-transplant predicts the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Phillips, E.
    Holroyd, A.
    Szydlo, R.
    Marin, D.
    Foroni, L.
    Milojkovic, D.
    de Lavallade, H.
    Gabriel, I.
    Sargent, J.
    Le Dieu, R.
    Goldman, J.
    Apperley, J. F.
    Rezvani, K.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S365 - S365
12345